ATEC (Alphatec Holdings) 3-Year RORE % : -19.36% (As of Mar. 2026)


ATEC Alphatec Holdings Inc ATEC
66 GF Score
Price $8.65
GF Value $15.29
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Alphatec Holdings 3-Year RORE %?

Alphatec Holdings ATEC -8.95% 66 3-Year RORE % is -19.36 as of Mar. 2026. GuruFocus rates ATEC with a GF Score™ of 66/100 and a GF Value™ of $15.29 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 782 Medical Devices & Instruments companies, Alphatec Holdings ranks worse than 64.96% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Alphatec Holdings's 3-Year RORE % for the quarter that ended in Mar. 2026 was -19.36%.

The industry rank for Alphatec Holdings's 3-Year RORE % or its related term are showing as below:

ATEC's 3-Year RORE % is ranked worse than
64.96% of 782 companies
in the Medical Devices & Instruments industry
Industry Median: -4.31 vs ATEC: -19.36

Alphatec Holdings  (NAS:ATEC) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Alphatec Holdings 3-Year RORE % Related Terms


Alphatec Holdings 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for Alphatec Holdings's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alphatec Holdings 3-Year RORE % Chart

Alphatec Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.13 7.28 1.56 -7.93 -16.48

Alphatec Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.11 -9.52 -12.27 -16.48 -19.36

ATEC vs IART, AHCO, INSP: 3-Year RORE % Comparison

For the Medical Devices subindustry, Alphatec Holdings's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alphatec Holdings 3-Year RORE % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Alphatec Holdings's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Alphatec Holdings's 3-Year RORE % falls into.


ATEC
66GF Score
Alphatec Holdings Inc ATEC
3-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alphatec Holdings 3-Year RORE % Calculation

Alphatec Holdings's 3-Year RORE % for the quarter that ended in Mar. 2026 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( -0.82--1.49 )/( -3.46-0 )
=0.67/-3.46
=-19.36 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of -19.36 mean?
Alphatec Holdings (ATEC) has a 3-Year RORE % of -19.36 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Alphatec Holdings and its competitors. According to the industry distribution chart, Alphatec Holdings ranks #508 out of 782 companies in the Medical Devices & Instruments industry, placing it in the top 65%.
Is Alphatec Holdings' 3-Year RORE % too high?
Alphatec Holdings' current 3-Year RORE % is -19.36. Based on the distribution chart, Alphatec Holdings ranks #508 out of 782 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Alphatec Holdings has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Alphatec Holdings' 3-Year RORE % compare to IART and AHCO?
According to the Medical Devices & Instruments industry distribution chart, Alphatec Holdings ranks #508 out of 782 companies for 3-Year RORE %. This places Alphatec Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Medical Devices & Instruments company?
A good 3-Year RORE % depends on the Medical Devices & Instruments industry context. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Alphatec Holdings and its competitors. Alphatec Holdings's current 3-Year RORE % is -19.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alphatec Holdings stock overvalued right now?
Based on GuruFocus' analysis, Alphatec Holdings (ATEC) is currently considered Possible Value Trap. The stock's GF Value™ is $15.29, compared to a current price of $8.65 — trading 43.4% below its estimated fair value. The current 3-Year RORE % is -19.36. Alphatec Holdings' overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Alphatec Holdings (ATEC), the current 3-Year RORE % is -19.36 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alphatec Holdings (ATEC) Overvalued in 2026?

Based on GuruFocus' analysis, Alphatec Holdings stock appears to be undervalued. The current stock price of $8.65 is trading 43.4% below its estimated GF Value™ of $15.29. GuruFocus considers Alphatec Holdings to be Possible Value Trap.

Key valuation signals for ATEC:

  • 3-Year RORE %: -19.36
  • GF Value™: $15.29 vs. price of $8.65 (43.4% below fair value)
  • GF Score™: 66/100 with 5 warning signs

No single metric tells the full story. See the ATEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Alphatec Holdings Business Description

Other Exchanges L1Z1:Germany
Address 1950 Camino Vida Roble, Carlsbad, CA, USA, 92008
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.
66GF Score

Get the complete analysis for ATEC

3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.65
Price
$15.29
GF Value